Sigma Investment Counselors Inc. Cuts Stake in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Sigma Investment Counselors Inc. lessened its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 3.6% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 18,331 shares of the medical equipment provider's stock after selling 685 shares during the quarter. Sigma Investment Counselors Inc.'s holdings in Intuitive Surgical were worth $9,568,000 at the end of the most recent quarter.

A number of other large investors have also recently modified their holdings of ISRG. Howard Capital Management Group LLC lifted its position in Intuitive Surgical by 4.5% in the 3rd quarter. Howard Capital Management Group LLC now owns 2,125 shares of the medical equipment provider's stock worth $1,044,000 after buying an additional 92 shares during the last quarter. Foundations Investment Advisors LLC lifted its position in Intuitive Surgical by 8.5% in the 3rd quarter. Foundations Investment Advisors LLC now owns 590 shares of the medical equipment provider's stock worth $290,000 after buying an additional 46 shares during the last quarter. Private Advisor Group LLC lifted its position in Intuitive Surgical by 6.4% in the 3rd quarter. Private Advisor Group LLC now owns 14,910 shares of the medical equipment provider's stock worth $7,325,000 after buying an additional 891 shares during the last quarter. McAdam LLC bought a new stake in Intuitive Surgical in the 3rd quarter worth approximately $225,000. Finally, DT Investment Partners LLC lifted its position in Intuitive Surgical by 80.0% in the 3rd quarter. DT Investment Partners LLC now owns 81 shares of the medical equipment provider's stock worth $40,000 after buying an additional 36 shares during the last quarter. Institutional investors own 83.64% of the company's stock.

Wall Street Analysts Forecast Growth

ISRG has been the subject of a number of recent research reports. Truist Financial boosted their target price on Intuitive Surgical from $640.00 to $666.00 and gave the stock a "buy" rating in a research report on Friday, January 24th. Wells Fargo & Company boosted their target price on Intuitive Surgical from $630.00 to $687.00 and gave the stock an "overweight" rating in a research report on Friday, January 24th. Piper Sandler restated an "overweight" rating and issued a $670.00 target price (up previously from $538.00) on shares of Intuitive Surgical in a research report on Friday, January 24th. Raymond James lifted their price target on Intuitive Surgical from $560.00 to $688.00 and gave the stock an "outperform" rating in a research note on Friday, January 24th. Finally, Morgan Stanley raised Intuitive Surgical from an "equal weight" rating to an "overweight" rating and lifted their price target for the stock from $522.00 to $650.00 in a research note on Monday, December 2nd. One analyst has rated the stock with a sell rating, five have assigned a hold rating and sixteen have assigned a buy rating to the company's stock. According to MarketBeat, the company currently has a consensus rating of "Moderate Buy" and a consensus target price of $613.10.

Intuitive Surgical Stock Performance

Shares of NASDAQ:ISRG traded down $17.27 during midday trading on Tuesday, reaching $573.74. 2,548,276 shares of the company's stock traded hands, compared to its average volume of 1,739,679. The company has a market cap of $204.35 billion, a price-to-earnings ratio of 89.51, a P/E/G ratio of 5.85 and a beta of 1.39. Intuitive Surgical, Inc. has a one year low of $364.17 and a one year high of $616.00. The stock has a 50 day moving average of $567.01 and a 200 day moving average of $527.27.

Insider Activity at Intuitive Surgical

In related news, Director Amal M. Johnson sold 4,635 shares of the company's stock in a transaction on Tuesday, January 28th. The stock was sold at an average price of $566.60, for a total transaction of $2,626,191.00. Following the completion of the sale, the director now owns 12,275 shares in the company, valued at approximately $6,955,015. This represents a 27.41 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CFO Jamie Samath sold 269 shares of the company's stock in a transaction on Monday, February 10th. The shares were sold at an average price of $590.00, for a total value of $158,710.00. Following the sale, the chief financial officer now owns 3,282 shares of the company's stock, valued at approximately $1,936,380. This trade represents a 7.58 % decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 6,240 shares of company stock worth $3,529,040. 0.80% of the stock is owned by insiders.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.